Sat.Jan 30, 2021 - Fri.Feb 05, 2021

article thumbnail

White paper reveals pathway for digital therapeutics use in Italy

pharmaphorum

A white paper has outlined a pathway that could allow Italy to realise the potential of digital therapeutics (DTx). The official journal of the Smith Kline Foundation, Tendenze Nuove, has published the paper entitled “Digital Therapeutics, an Opportunity for Italy” earlier this month. The book features insights and recommendations from 40 leading experts in the field, who hope that Italy will begin to follow in the footsteps of early adopters of digital therapeutics such as Germany, France and

article thumbnail

New analysis backs safety, efficacy of AZ/Oxford COVID-19 jab

Pharma Times

The data show 100% protection against severe disease, hospitalisation and death, greater vaccine efficacy with an inter-dose interval of 12 weeks or more, and the potential for reduced asymptomatic transmission

Vaccines 122
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

McKinsey Settles for $573 Million Over Role in Opioid Crisis

NY Times

The consulting firm has reached the agreement with 47 states because of its advice to drugmakers, including Purdue Pharma, the manufacturer of OxyContin.

124
124
article thumbnail

Family cancer experience informs eHealth company

Outsourcing Pharma

The founder of Andaman7âs leukemia diagnosis, and his sonâs experience with bone cancer, have helped inform the firm's tech and patient-centric approach.

126
126
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Not every cough is COVID – MSD UK’s lung cancer campaign

pharmaphorum

For World Cancer Day, David Long, business unit director of Oncology at MSD UK tells pharmaphorum about the company’s ‘Do It Yourself’ campaign launched in the North East to raise awareness of lung cancer symptoms. As COVID cases surged last year, lung cancer referrals dropped in the UK, causing alarm to the UK Lung Cancer Coalition (UKLCC), an alliance of the UK’s leading lung cancer experts, senior NHS professionals, charities, and healthcare companies.

article thumbnail

NICE green light for GSK's Nucala

Pharma Times

Final guidance on the drug's use to treat patients with severe eosinophilic asthma on the NHS has now been published

118
118

More Trending

article thumbnail

Webinar Recap – Video, Voice, and Virtual: Applying New Digital Technology to Enhance Customer Experience with PMN

Pharma Marketing Network

Moderator and Panelists: Amy Turnquist , EVP, Digital, eHealthcare Solutions (Moderator). Ryan Billings , U.S. Oncology Digital Marketing & Customer Experience at GSK. Desiree Priestley , Director, Patient Support Strategy & Insights at Otsuka America Pharmaceutical. Kristen Palmer Winters , Customer Experience (CX), Americas Hub, Digital & Commercial Innovation, Bayer.

98
article thumbnail

Why we need the human element of remote clinical trials

pharmaphorum

Over the last year, we’ve noticed that “connectivity” doesn’t always equate to “connected” – and that’s just as true in the realm of clinical trials as it is in our personal lives. Amanda Barrell reports from a panel at the Patients as Partners Europe conference on remote clinical trials. Decentralised trials have been growing in popularity in recent years, and the COVID-19 pandemic has served to accelerate that progress.

Hospitals 133
article thumbnail

The Biosimilar Landscape: An Overview of Regulatory Approvals by the EMA and FDA

Drug Patent Watch

This article was originally published by Ioana Gherghescu and Begoña Delgado-Charro in Pharmaceutics 2021, 13(1) under a Creative Commons Attribution License. Abstract Biosimilar medicines expand the biotherapeutic market and improve…. The post The Biosimilar Landscape: An Overview of Regulatory Approvals by the EMA and FDA appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

As Virus Variants Spread, ‘No One Is Safe Until Everyone Is Safe’

NY Times

Rich countries are cornering the market on coronavirus vaccines, leaving poorer regions as potential breeding grounds for variants, like one found in South Africa, that could make vaccines less effective.

Vaccines 105
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

UK trial explores impact of combining different COVID-19 vaccines

Outsourcing Pharma

An Oxford University trial, a world first, is looking at whether inoculating volunteers with doses of different combinations of two currently approved COVID-19 vaccines is effective.

article thumbnail

Almirall, Happify partner on digital tool for psoriasis mental health

pharmaphorum

It’s well recognised that people with psoriasis can develop depression or anxiety, particularly in moderate or severe cases where a sizeable part of the body can have skin lesions. Now, drugmaker Almirall and digital health firm Happify are working on a tool to support mental health in these patients. Almirall is a specialist in psoriasis therapies with drugs like Skilarence (dimethyl fumarate) and Ilumetri (tildrakizumab), while Happify’s app is designed to drive away negative thoughts through

124
124
article thumbnail

Which pharmaceutical companies have the most drug patents in Slovenia?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Slovenia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Slovenia? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Millions could benefit from genetic screening before prescribing, new research finds

Pharma Times

Research led by the University of East Anglia in collaboration Boots UK and Leiden University

123
123
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

How the Search for Covid-19 Treatments Faltered While Vaccines Sped Ahead

NY Times

Vaccine development exceeded everyone’s expectations. But the next few months will still bring many sick people — and doctors have woefully few drugs with which to treat them.

article thumbnail

AstraZeneca to supply nine million more vaccines to EU

pharmaphorum

The diplomatic row that broke out last week over the supply of AstraZeneca’s vaccine to Europe appears to have cooled after the UK pharma agreed to supply an extra nine million doses. At the end of last week, the European Commission was forced into an embarrassing U-Turn when it tried to impose restrictions on COVID-19 vaccines exported from the bloc.

Vaccines 114
article thumbnail

Lung cancer community severely impacted by COVID: report

Outsourcing Pharma

A report from the World Economic Forum and Lung Ambition Alliance outlines the impacts the pandemic is having on lung cancer diagnoses and treatment.

98
article thumbnail

AstraZeneca and UCL to collaborate on two immuno-oncology projects

Pharma Times

Projects will investigate immune checkpoints and contribute to the development of new cancer treatments

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

DrugPatentWatch featured in Inc Magazine

Drug Patent Watch

DrugPatentWatch was featured in a recent article by Inc. Magazine. In their coverage of Mark Cuban’s new pharma company, they cited our published interview where Mark Cuban Sounds off on Drug Prices.…. The post DrugPatentWatch featured in Inc Magazine appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

UK biotech investment at record levels amid COVID-19

pharmaphorum

New figures have confirmed that the UK’s biotech sector received a massive boost from the COVID-19 pandemic last year, with investment levels soaring to £2.8 billion ($3.8 billion) from a level of £1.3 billion in 2019. That makes 2020 a new record year for the sector, exceeding the previous investment high of £2.2 billion in 2018, according to the latest BioIndustry Association (BIA) and Clarivate report, and represents a 1,000% increase on 2012.

Vaccines 111
article thumbnail

Merck Digital Ethics Advisory Panel tackles tech questions

Outsourcing Pharma

The panel is intended to address ethical matters that arise around evolving data and digital conduct for all of its various business sectors.

102
102
article thumbnail

Patients gain early access to Pfizer's atopic dermatitis drug

Pharma Times

The MHRA has issued a positive scientific opinion for abrocitinib allowing its use via the early access to medicines scheme (EAMS)

92
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

How Scientists Shot Down Cancer’s ‘Death Star’

NY Times

No drug could touch a quivering protein implicated in a variety of tumors. Then one chemist saw an opening.

104
104
article thumbnail

A Message to Pharma CIOs: Optimizing Salesforce Improves Security and Compliance

pharmaphorum

By Jennifer Mercer , CEO of Metazoa. Jennifer Mercer is Co-founder and CEO of Metazoa, developers of Snapshot, an admin and developer tool for companies with complex Salesforce orgs that is used by over 60% of Fortune 100 companies. . Salesforce org management is usually not the headliner for CIOs and CTOs looking to catch up on executive-level trends and issues pertaining to technology.

article thumbnail

Parexel, Signify join forces to boost trial inclusivity

Outsourcing Pharma

The firms will work to develop solutions centered on increasing diversity and inclusivity in clinical research, and addressing healthcare disparities.

93
article thumbnail

Kesimpta and Vazkepa among latest CHMP recommendations

Pharma Times

Bumper meeting saw 13 new medicines recommended for approval

124
124
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Top E.U. Official Comes Under Fire in Vaccine Wars

NY Times

Ursula von der Leyen has largely stayed away from the limelight while driving the handling of a crisis and letting subordinates take the blame.

article thumbnail

UK patient group warns COVID could limit access to Novartis’ new eye drug

pharmaphorum

NICE has recommended regular NHS funding for Novartis’ long-acting eye drug Beovu (brolucizumab) in England and Wales – but a patient group warned that access could be limited until the pandemic recedes because of disruption to ophthalmology clinics. In final guidance NICE said trials have shown Novartis’ Beovu has similar efficacy in wet advanced macular degeneration (AMD) to rival Eylea (aflibercept) from Bayer/Regeneron and Novartis predecessor Lucentis (ranibizumab).

article thumbnail

Super Bowl player donates to help fund cancer research

Outsourcing Pharma

William Gholston, with the Tampa Bay Buccaneers football team, is donating to the Moffitt Cancer Center to fund research into cancer treatment disparities.

89
article thumbnail

EU approves Chiesi’s triple combination asthma therapy Trimbow

Pharma Times

European Commission has authorised treatment for uncontrolled asthma patients

112
112
article thumbnail

Si la vacunación contra la COVID-19 no avanza en los países pobres, frenar las variantes será más difícil en el mundo

NY Times

Mientras las regiones con más recursos compran vacunas, otras podrían convertirse en caldo de cultivo de mutaciones que podrían hacer que las vacunas en general fueran menos eficaces.